Literature DB >> 21920445

14-3-3 proteins in neurodegeneration.

Petra Steinacker1, Alastair Aitken, Markus Otto.   

Abstract

Among the first reported functions of 14-3-3 proteins was the regulation of tyrosine hydroxylase (TH) activity suggesting a possible involvement of 14-3-3 proteins in Parkinson's disease. Since then the relevance of 14-3-3 proteins in the pathogenesis of chronic as well as acute neurodegenerative diseases, including Alzheimer's disease, polyglutamine diseases, amyotrophic lateral sclerosis and stroke has been recognized. The reported function of 14-3-3 proteins in this context are as diverse as the mechanism involved in neurodegeneration, reaching from basal cellular processes like apoptosis, over involvement in features common to many neurodegenerative diseases, like protein stabilization and aggregation, to very specific processes responsible for the selective vulnerability of cellular populations in single neurodegenerative diseases. Here, we review what is currently known of the function of 14-3-3 proteins in nervous tissue focussing on the properties of 14-3-3 proteins important in neurodegenerative disease pathogenesis. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920445     DOI: 10.1016/j.semcdb.2011.08.005

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  37 in total

1.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  14-3-3 Proteins in the regulation of rotenone-induced neurotoxicity might be via its isoform 14-3-3epsilon's involvement in autophagy.

Authors:  Yan Sai; Kaige Peng; Feng Ye; Xiaoguang Zhao; Yuanpeng Zhao; Zhongmin Zou; Jia Cao; Zhaojun Dong
Journal:  Cell Mol Neurobiol       Date:  2013-09-04       Impact factor: 5.046

Review 3.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

4.  14-3-3 Isoforms Differentially Regulate NFκB Signaling in the Brain After Ischemia-Reperfusion.

Authors:  Xin-Yu Zhou; Dian Xing Hu; Ruo Qiao Chen; Xiao Qian Chen; Wan-Li Dong; Cheng-la Yi
Journal:  Neurochem Res       Date:  2017-04-19       Impact factor: 3.996

Review 5.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

6.  Regulation of 14-3-3β/α gene expression in response to salinity, thermal, and bacterial stresses in Siberian sturgeon (Acipenser baeri).

Authors:  Xiaowen Wang; Guoqing Ma; Hua Zhu
Journal:  Fish Physiol Biochem       Date:  2019-12-17       Impact factor: 2.794

7.  Changes in Brain 14-3-3 Proteins in Response to Insulin Resistance Induced by a High Palatable Diet.

Authors:  Hugo Bock; Aline Rigon Zimmer; Eduardo Rigon Zimmer; Diogo Onofre Gomes de Souza; Luis Valmor Cruz Portela; Maria Luiza Saraiva-Pereira
Journal:  Mol Neurobiol       Date:  2014-10-04       Impact factor: 5.590

Review 8.  14-3-3 and aggresome formation: implications in neurodegenerative diseases.

Authors:  Baohui Jia; Yuying Wu; Yi Zhou
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

9.  Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface.

Authors:  Ingrid J De Vries-van Leeuwen; Daniel da Costa Pereira; Koen D Flach; Sander R Piersma; Christian Haase; David Bier; Zeliha Yalcin; Rob Michalides; K Anton Feenstra; Connie R Jiménez; Tom F A de Greef; Luc Brunsveld; Christian Ottmann; Wilbert Zwart; Albertus H de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-15       Impact factor: 11.205

10.  Establishing a novel knock-in mouse line for studying neuronal cytoplasmic dynein under normal and pathologic conditions.

Authors:  Jun Zhang; Alison E Twelvetrees; Jacob E Lazarus; Kiev R Blasier; Xuanli Yao; Nirja A Inamdar; Erika L F Holzbaur; K Kevin Pfister; Xin Xiang
Journal:  Cytoskeleton (Hoboken)       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.